Research

The human genome is a complete set of a person’s DNA. Serving as a blueprint for all cells in the body, the genome contains about 20,000 genes. The first human […]

We are entering an era of unprecedented opportunity for understanding and treating Lewy body dementia (LBD). Our newest white paper, Lewy Body Dementia: The State of the Science provides the […]

Dementia is one of the most expensive diseases in the United States, increasing healthcare costs 3 times over those without dementia. Until now, studies on the costs of different dementia […]

A new study reveals family caregivers have an increase in the beneficial stress hormone DHEA-S on days when they use an adult day service for their relatives with dementia. DHEA-S […]

The rate of progression in Lewy body dementia (LBD) is hard to predict at the time of diagnosis. New research indicates the presence of a second neurodegenerative disease process, Alzheimer’s […]

Because Lewy body dementia is the most misdiagnosed form of dementia, LBDA developed a useful checklist to help physicians and their patients identify key LBD symptoms used to make a […]

If you talk with families, many will share that getting a diagnosis for one specific form of LBD, called dementia with Lewy bodies (DLB), was a challenge.  Sometimes the diagnosis […]

Drowsiness and daytime sleepiness (despite getting adequate sleep the night before) are often described by individuals with dementia with Lewy bodies (DLB) and their caregivers. This is reported even in […]

With all the recent news about failed clinical trials for disease-modifying treatments for Alzheimer’s disease, a little encouraging news is timely. ACADIA Pharmaceuticals announced an early end to one of […]

Visual hallucinations are a core feature of dementia with Lewy bodies, occurring in 32 to 85 percent of autopsy-confirmed cases. Individuals with Alzheimer’s disease also experience hallucinations, though to a […]